Lloyd A Rowland - Net Worth and Insider Trading
Lloyd A Rowland Net Worth
The estimated net worth of Lloyd A Rowland is at least $138,645 dollars as of 2024-12-01. Lloyd A Rowland is the General Counsel of CytomX Therapeutics Inc and owns about 130,797 shares of CytomX Therapeutics Inc (CTMX) stock worth over $138,645. Details can be seen in Lloyd A Rowland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lloyd A Rowland has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lloyd A Rowland
Lloyd A Rowland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lloyd A Rowland owns 2 companies in total, including CytomX Therapeutics Inc (CTMX) , and Xencor Inc (XNCR) .
Click here to see the complete history of Lloyd A Rowland’s form 4 insider trades.
Insider Ownership Summary of Lloyd A Rowland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | General Counsel |
| XNCR | Xencor Inc | 2014-08-29 | Sr. V.P. and General Counsel |
Lloyd A Rowland Latest Holdings Summary
Lloyd A Rowland currently owns a total of 1 stock. Lloyd A Rowland owns 130,797 shares of CytomX Therapeutics Inc (CTMX) as of August 20, 2024, with a value of $138,645.
Latest Holdings of Lloyd A Rowland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | 130,797 | 1.06 | 138,645 |
Holding Weightings of Lloyd A Rowland
Lloyd A Rowland Form 4 Trading Tracker
According to the SEC Form 4 filings, Lloyd A Rowland has made a total of 6 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 4,181 shares on August 20, 2024, which brought Lloyd A Rowland around $5,143.
Insider Trading History of Lloyd A Rowland
- 1
Lloyd A Rowland Trading Performance
GuruFocus tracks the stock performance after each of Lloyd A Rowland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lloyd A Rowland is -1.32%. GuruFocus also compares Lloyd A Rowland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lloyd A Rowland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lloyd A Rowland's insider trading performs compared to the benchmark.
Performance of Lloyd A Rowland
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.3 | | | | | |
| Relative Return to S&P 500(%) | 2.2 | | | | | |
Lloyd A Rowland Ownership Network
Lloyd A Rowland Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Lloyd A Rowland is the General Counsel of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Lloyd A Rowland made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 19,012. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 18,939 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 0 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Lloyd A Rowland Mailing Address
Above is the net worth, insider trading, and ownership report for Lloyd A Rowland. You might contact Lloyd A Rowland via mailing address: Amylin Pharmaceuticals Inc, 9360 Towne Centre Dr, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
